Search Results - "Goyal, Shreya Prasad"

Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer by Rehman, Hasan, Chi, Jeffrey, Hakim, Nausheen, Goyal, Shreya Prasad, Olazagasti, Coral, Jose, Jyothi, Moriarty, Linda, Saif, Muhammad Wasif

“…Background: Treatment with gemcitabine/nab-paclitaxel confers a survival benefit over gemcitabine monotherapy in patients with advanced pancreatic cancer…”
Get full text

Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged > 65 years with advanced pancreatic cancer (APC) by Rehman, Hasan, Chi, Jeffrey, Hakim, Nausheen, Goyal, Shreya Prasad, Olazagasti, Coral, Jose, Jyothi, Moriarty, Linda, Saif, Wasif M.

“…Abstract only 705 Background: Treatment with gemcitabine/nab-paclitaxel confers a survival benefit over gemcitabine monotherapy in APC. However, such treatment…”
Get full text

First analysis of same-day pegfilgrastim use with concurrent capecitabine-based regimens in pts with GI malignancies by Hakim, Nausheen, Chi, Jeffrey, Rehman, Hasan, Goyal, Shreya Prasad, Olazagasti, Coral, Moriarty, Linda, Jose, Jyothi, Lamont, Carol, Saif, Wasif M.

“…Abstract only 817 Background: Pegfilgastrim is administered 24 hrs after chemotherapy to reduce risks of myelosuppression. This requires an additional clinic…”
Get full text

Liver-directed therapy (LDT) and systemic chemotherapy for pancreatic adenocarcinoma with liver metastases (PCLM): Experience of 12 years by Goyal, Shreya Prasad, Jose, Jyothi, Greben, Craig R., Lobko, Igor, Grimaldi, Gregory Michael, Ghaly, Maged, Daly, Kevin P, Saif, Wasif M.

“…Abstract only e16768 Background: PCLM has a poor prognosis with a median survival of ≤6 months. Treatment options are limited as only few patients can undergo…”
Get full text

Reducing emergency department utilization by improving patient access to their oncology care team by Philip, Tony, Gleason, Karen, Nekola, Claire, Tucker, Todd, Paul Valadez, Jenny, Prasad-Goyal, Shreya, Meisels, Samantha, Bowman, Ronda Marie, Kaufman, Laura

“…Abstract only 77 Background: At Monter Cancer Center, we observed that when patients on active intravenous chemotherapy presented to our local ED about 70%…”
Get full text